JellyBlue Reviews: Is the “Clinically Dosed” Claim Accurate?
“Clinically dosed” is the most checkable claim in supplement marketing, and almost nobody checks it. JellyBlue makes the claim four separate ways on its sales page. We tested it against every ingredient.
Of seven actives, one is at a research dose, two are far below the studies cited for them, and four have no published amount to assess.
Where the claim appears
The official page makes this argument repeatedly. A feature card headed “Clinically-Informed Dosing” states the formula contains strong ingredients in the ideal dosage. The hero copy says the actives arrive “all in optimal therapeutic doses.” A comparison table gives JellyBlue a tick for “Clinically-Dosed Ingredients” that competitors do not get. And a body paragraph attacks “other supplements that use underdosed ‘fairy dust’ ingredients.”
Four assertions, one of them explicitly comparative. That is a claim the page has chosen to stand on.
The test
For each ingredient: find the amount on the panel, find the dose used in the research being cited for it, and divide. Where no amount is published, the claim is unverifiable rather than false — which is a different failure but still a failure, because an unverifiable claim cannot support a comparative attack on rivals.
Check the current JellyBlue discount
Multi-bottle pricing drops to $49 a bottle on the largest package. Pricing verified 2026-08-19 — confirm your total at checkout.
See JellyBlue pricingAffiliate link. We may earn a commission at no additional cost to you. Verified 2026-08-19.
The results
Tongkat Ali — passes. 200 mg on the label against 200–400 mg in human trials. This is a correct dose and should be said clearly.
Ashwagandha — fails. 100 mg against the 600 mg used in the trial the page cites by name. Roughly one sixth.
Maca — fails. 100 mg against 1,500–3,000 mg in maca research. Roughly 3–7%.
L-Arginine — unverifiable, and almost certainly fails on arithmetic. No amount published; research uses 3–6 grams; a gummy cannot carry that.
Horny Goat Weed — unverifiable. No amount, no icariin standardisation, and no settled human dose to compare against.
Beet Root — unverifiable. No amount, no nitrate content stated.
Grape Seed — unverifiable. No amount published against a 150–300 mg research range.
The verdict on the claim
One of seven passes. Two demonstrably fail against studies the seller itself selected. Four cannot be assessed because the numbers are not published.
A brand cannot simultaneously withhold its doses and claim they are clinically appropriate. Publishing the full panel would resolve this instantly — and if the undisclosed four are well dosed, saying so would be free marketing. The silence is the informative part.
How to apply this elsewhere
This test works on any supplement in any category. Find one amount, find one study, divide. If a brand publishes doses that survive the division, that is the strongest quality signal available in a market with no pre-market review. If it does not publish them at all, treat “clinically dosed” as marketing language rather than a fact.
Independent background reading, none of it selling anything: MedlinePlus on dietary supplements, the Urology Care Foundation and NHLBI on sleep. For the applied version of this on our own pages, see what the product actually is or the JellyBlue official website reference.
What we would do
Take the label to a pharmacist before ordering, get a baseline blood panel so you have something to compare against, and choose the three-bottle package rather than the six — it covers the ninety days the seller itself recommends without leaving you holding four unopened bottles months after the refund window has closed. Diarise day 50 on the day you order.
How to verify any of this
Every figure above comes from a source you can check yourself: the printed Supplement Facts panel on the bottle, the official order page, the published return terms, or peer-reviewed literature. Where an amount is not disclosed by the manufacturer, we say so rather than estimating it. If you find something here that is out of date or wrong, tell us and we will re-check it and re-date the page.
Frequently asked
One of its seven actives is at a researched dose. Two disclosed doses fall well short of the cited studies, and four amounts are not published.
Tongkat ali at 200 mg, which matches the range used in its human trials.
We do not know. Publishing them would settle the question immediately, which is why the absence is worth noticing.
Disclaimer. This formula contains ingredients the seller describes as PDE5-active, alongside two vasodilators. PDE5 inhibitors are contraindicated with nitrate medicines such as nitroglycerin and isosorbide. Show the label to a pharmacist before ordering, particularly if you take any heart or blood pressure medication. These statements have not been evaluated by the Food and Drug Administration, and JellyBlue is not intended to diagnose, treat, cure or prevent any disease. New or worsening erectile difficulty is a recognised early marker of cardiovascular disease and warrants medical assessment rather than a supplement purchase.
Affiliate disclosure. This page contains affiliate links. We may earn a commission if you purchase through them, at no additional cost to you. That does not change what we publish — see our full disclosure.